{"database": "openregs", "table": "documents", "rows": [["FDA-2005-D-0208-0007", "FDA", "FDA-2005-D-0208", "Reference 5 - Draft Guidance for Industry General Considerations for Pediatric Pharmacokinetic Studies for Drugs and Biological Products, November 1998 [FDA-2005-D-0208-0004] - Draft Guidance Document", "Supporting & Related Material", "REF-Reference (internal unless indicated)", "2008-07-18T04:00:00Z", 2008, 7, null, null, "2008-07-18T20:40:36Z", null, 0, 0, "0900006480676155"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2005-D-0208-0007"], "units": {}, "query_ms": 12.123114080168307, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}